David J. Friedman, PhD, is a postdoctoral fellow in the Tumor Microenvironment Laboratory of Dr. Kristina H. Young, MD PhD, at the Earle A. Chiles Research Institute, part of Providence Cancer Institute in Portland, Oregon. His research focuses on understanding how radiation therapy shapes antitumor immune responses, with particular emphasis on T-cell trafficking, immune suppression within the tumor microenvironment, and strategies to enhance the efficacy of radiation and immunotherapy combinations. Dr. Friedman earned his PhD in Biomedical Sciences-Immunology from Mayo Clinic Graduate School of Biomedical Sciences in 2022 and received his BA in Biology from Whitman College in 2013. Prior to his current position, he served as a postdoctoral fellow at Mayo Clinic Arizona and as a research associate at the Earle A. Chiles Research Institute. His research has contributed to advances in cancer immunology, radiation biology, and innate immune signaling. He has authored studies investigating tumor-associated glycosylation, STING signaling, regulatory T-cell trafficking, and radiation-induced immune responses. Dr. Friedman has received multiple American Association of Immunologists (AAI) Trainee Abstract Awards, including awards in 2019, 2021, 2022, and 2023.
Disclosures:
- Employment: Providence Health and Services:Postdoctoral Fellow:Employee
- Compensation: :Role Topic Description-End Date:
- Ownership: none
- Leadership: none